Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 16/20 | 0.59 |
| ▸ | NPY1R | P25929 | 10/20 | 0.59 |
| ▸ | NPY5R | Q15761 | 9/20 | 0.59 |
| ▸ | NPY2R | P49146 | 6/20 | 0.59 |
| ▸ | TFPI | P10646 | 1/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.54 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22413053 | 0.92 | NPY4R (0.65) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL22413050 | 0.92 | NPY4R (0.65) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL31269521 | 0.88 | NPY4R (0.64) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL29548324 | 0.85 | TFPI (0.63) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL31013860 | 0.85 | NPY4R (0.64) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL30354439 | 0.85 | NPY4R (0.64) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL31614421 | 0.84 | OPRD1 (0.57) | NPY4RNPY1RNPY2ROPRM1OPRD1 | |
| SCHEMBL30844091 | 0.83 | NPY4R (0.63) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL2182662 | 0.83 | NPY4R (0.70) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31614425 | 0.82 | OPRD1 (0.56) | NPY4RNPY1RNPY2ROPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113573723-A | Synthetic neuromodulatory peptides | 拉托科公司 | 2021-10-29 | — | — | CN | disclosed |